Information:
Error:
ID
21784
Description
A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00299104
Link
https://clinicaltrials.gov/show/NCT00299104
Keywords
Versions (1)
- 4/30/17 4/30/17 -
Uploaded on
April 30, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Rheumatoid Arthritis NCT00299104
Eligibility Rheumatoid Arthritis NCT00299104
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT00299104
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Age
Item
adult patients 18-80 years of age
boolean
C0001779 (UMLS CUI [1])
Rheumatoid Arthritis: Duration
Item
ra for ≥ 2 months;
boolean
C0872146 (UMLS CUI [1,1])
C0003873 (UMLS CUI [1,2])
C0003873 (UMLS CUI [1,2])
Outpatient
Item
receiving outpatient treatment
boolean
C0029921 (UMLS CUI [1])
Methotrexate Treatment
Item
patients naive to, and considered to be candidates for, methotrexate treatment
boolean
C0746573 (UMLS CUI [1])
Rheumatic autoimmune disease
Item
rheumatic autoimmune disease other than ra, or significant systemic involvement secondary to ra
boolean
C0004364 (UMLS CUI [1,1])
C0035435 (UMLS CUI [1,2])
C0035435 (UMLS CUI [1,2])
Inflammatory joint disease or systemic autoimmune disorder
Item
inflammatory joint disease other than ra, or other systemic autoimmune disorder
boolean
C0683381 (UMLS CUI [1])
C1384868 (UMLS CUI [2])
C1384868 (UMLS CUI [2])
Juvenile rheumatoid arthritis or age of onset
Item
diagnosis of juvenile rheumatoid arthritis, or ra before the age of 16
boolean
C0311221 (UMLS CUI [1])
C0206132 (UMLS CUI [2])
C0206132 (UMLS CUI [2])
Surgery
Item
surgery within 12 weeks of study
boolean
C0543467 (UMLS CUI [1])
Prior treatment
Item
previous treatment with any approved or investigational biologic agent for ra, an anti-alpha4-integrin antibody or co-stimulation modulator, or cell-depleting therapy
boolean
C1514463 (UMLS CUI [1])
Concurrent treatment
Item
concurrent treatment with any biologic agent or dmard other than methotrexate
boolean
C0013227 (UMLS CUI [1])